Navigation Links
Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
Date:10/28/2009

BAD HOMBURG, Germany and LACHEN, Switzerland, Oct. 28 /PRNewswire/ -- Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi's HESylation® Technology to develop a HESylated recombinant protein.

Under the agreement, Fresenius Kabi will license its proprietary HESylation® Technology to Octapharma. This technology platform is based on hydroxyethyl starch ("HES") which will be combined with a recombinant protein from Octapharma's human cell-line platform -- this combination is intended to generate a therapeutic protein with a superior product profile.

Fresenius Kabi will seek to adapt and optimize the protein modification by its HESylation® Technology and will afterwards be responsible for providing the appropriate HES derivative to Octapharma. Under the agreement, Octapharma will oversee the further development and commercialization. Fresenius Kabi will receive up-front and milestone payments, research funding and royalties on sales for licensing of the HESylation® Technology.

Octapharma's human cell-line platform

Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell lines. Over the last twelve years, Octapharma has successfully established the human HEK293F cell-line platform for the expression of a variety of recombinant therapeutic proteins on a commercial scale.

An investigational new drug application for Octapharma's human cell-line derived recombinant FVIII was filed in the U.S. in May 2008. Using a human cell-line expression system instead of e.g. hamster cell-lines is expected to result in possible advantages like improved protein functions, increased tolerability and the opportunity for reduced immunogenicity.

HESylation® Technology

HESylation® Technology is based on th
'/>"/>

SOURCE Octapharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
2. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
3. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
4. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
5. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
9. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
10. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
11. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 Pharma Major ... in ZAO "Biocom" in Russia subject ... the Russian pharmaceutical market which recorded RUB 765 billion in ... markets in the world in 2014 (IMS Health). For over ... expected to continue with this trend, projecting Russia ...
(Date:7/2/2015)... -- Konica Minolta, Inc. (Konica Minolta) ( Tokyo ... Technologica Ltda., an X-ray system equipment manufacturer based in ... Brazilian healthcare sales company, Konica Minolta Healthcare do ... Brazil market investment and growth With ... significant healthcare technical advancements and efficiencies are required. Aging ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION MEDICAL ... new E-CUBE Series ultrasound system. Developed to enhance user ... areas, the E-CUBE 15 EX produces superb image quality. ... performance in women,s health, general imaging, and shared service ... The latest in the renowned E-CUBE Series, the E-CUBE ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
... PLYMOUTH MEETING, Pa., Nov. 8, 2011   Health technology ... are the most serious device-related risks, and how can ... nonprofit that researches the best approaches to improving patient ... hospital,s patient safety initiatives with the release of its ...
... Alexza Pharmaceuticals, Inc. (Nasdaq:  ALXA) today announced that ... and Mental Health Congress, being held November 7 - ... Agitation with Inhaled Loxapine (AZ-004): Responder Analyses in Patients ... by Dr. James V. Cassella, Alexza,s Senior Vice President ...
Cached Medicine Technology:ECRI Institute Announces its Top 10 Health Technology Hazards for 2012 2ECRI Institute Announces its Top 10 Health Technology Hazards for 2012 3ECRI Institute Announces its Top 10 Health Technology Hazards for 2012 4Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference 2Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference 3Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference 4Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference 5
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report ... number of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war ... to American society right now," Becic said. "We must understand the magnitude of this ...
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly Tech Report, ... technology expert and special reporter for NewsWatch, conducted the review and shared with viewers ... , According to the U.S. Department of Energy, it’s very important to use energy-efficient ...
(Date:7/2/2015)... ... , ... Global leader and compression innovator, SIGVARIS North America, is ... For style that’s quick on its feet, men will love this fun new way ... everywhere because a simple change in socks can dramatically help improve overall leg health ...
(Date:7/2/2015)... Diego, CA (PRWEB) , ... July 02, 2015 , ... ... and a passion for social fitness. Built to function as a lifestyle community, Active ... giving them the opportunity to network, meet, and participate in discussions or group events. ...
Breaking Medicine News(10 mins):Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2
... several years of research into the gecko,s uncanny ability to ... have developed an adhesive that is the first to master ... feet. The material could prove useful for a range of ... tape or glue, the new material is crafted from millions ...
... events was also lower than researchers anticipated , , TUESDAY, ... comparing the real-life effectiveness of two different drug-coated stents, ... stents and a lower rate of problems than had ... 2,000 people who had these flexible tubes implanted to ...
... Focuses on E-Prescribing, Other Issues in,2008, ... seek common ground promoting bipartisan health care ... Allyson Schwartz, (D-Penn.), Lois,Capps, (D-Calif.), and Jason ... Care Task Force, which will focus on ...
... Inc.,(Amex: TTG ), a leading manufacturer of sterile ... tissue, will report,financial results for the first quarter ended ... will discuss these results in a,conference call scheduled for ... parties can access the call by dialing (888) 408-9532 ...
... Translation of Compendia Used to Ensure the,Quality of ... 29 The U.S.,Pharmacopeia is pleased to announce ... compendia, the United States Pharmacopeia and National,Formulary (USP-NF), ... for,2008, USP 31-NF 26, provides specifications needed to ...
... Scare in ABC,s "Eli,Stone", WHITE PLAINS, N.Y., Jan. ... of the U.S. Centers for Disease Control,and Prevention (CDC) ... by the suggestion in an upcoming episode of the ... which is no longer,used in vaccines -- may lead ...
Cached Medicine News:Health News:The pitter patter of little feet... climbing straight up a wall 2Health News:Study Finds Both Coated Stents Perform the Same 2Health News:Study Finds Both Coated Stents Perform the Same 3Health News:PCMA: 2008 Health Debate Highlights 'Workable Solutions' Like E-Prescribing 2Health News:Tutogen Medical, Inc. to Report First Quarter Fiscal 2008 Financial Results 2Health News:USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary 2Health News:Childhood Vaccines Save Lives, March Of Dimes Says 2Health News:Childhood Vaccines Save Lives, March Of Dimes Says 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: